Key oncogenes and candidate drugs for hepatitis-B-driven hepatocellular carcinoma progression

Together, eight key HB-LC genes play important cancer-promoting roles in LC, which may be the molecular mechanism by which HBV drives the development of LC.

Authors

Institutions

Publication Details

Journal
Discover Oncology
Published
2025-02-04
DOI
https://doi.org/10.1007/s12672-025-01851-6
Primary Topic
Hepatocellular Carcinoma Treatment and Prognosis
Type
article
Field-Weighted Citation Impact
0.00

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Key oncogenes and candidate drugs for hepatitis-B-driven hepatocellular carcinoma progression

Liqin Ruan, Weili Chen, Zhaoping Wu, Ningbo Fang et al.
Discover Oncology
Hepatocellular Carcinoma Treatment and Prognosis
article

Key oncogenes and candidate drugs for hepatitis-B-driven hepatocellular carcinoma progression

Liqin Ruan, Weili Chen, Zhaoping Wu, Ningbo Fang, Xiaoyong Wu, Xinhua Zhao
article en

Abstract

Together, eight key HB-LC genes play important cancer-promoting roles in LC, which may be the molecular mechanism by which HBV drives the development of LC.

Discover OncologyVol. 16(1)
Jiujiang First People's Hospital (CN)
Natural Science Foundation of Ningxia Province
Good health and well-being
Openalex Percentile: Top 97%
Hepatocellular Carcinoma Treatment and Prognosis
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.